REVIEW OF LITERATURE ON THE SPECIFICITY OF GENERAL PATHOMORPHOLOGICAL CHANGES IN SATELLITE STRUCTURES UNDER THE INFLUENCE OF CORONAVIRUS
Keywords:
placenta (maternal-placental system), stem villi, pregnancy, viral infections, SARS-CoV-2.Abstract
Viral infections observed during pregnancy can have a specific impact on the body, leading to various negative outcomes at different stages of pregnancy. This necessitates an understanding of the pathological processes occurring in the placenta (maternal-placental system). Women suffering from viral infections such as herpes, hepatitis, rubella, and measles experience changes in the placenta, which have been studied in this context. In our study, special attention is given to the morphological changes in the placenta resulting from the coronavirus infection (SARS-CoV-2), which has shocked the entire world. The main morphological changes observed in the placenta during COVID-19 infection are presented.
References
Arutyunov G.P., Tarlovskaya E.I., Arutyunov A.G., et al. International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV SARS-CoV-2): analysis of predictors of short-term adverse outcomes in COVID-19. Russian Journal of Cardiology. 2021;26(4):4470. (In Russian). doi:10.15829/1560-4071-2021-4470.
Bloise, E. et al. (2021). “Expression of SARS-CoV-2 entry factors in the human placenta throughout gestation.” American Journal of Obstetrics and Gynecology, 224(3):298.e1–298.e8. doi:10.1016/j.ajog.2020.10.008
Garrido-Pontnou, M. et al. (2021). “Diffuse trophoblast damage is the hallmark of SARS-CoV-2–associated fetal demise.” Modern Pathology, 34:1704–1709.
Hoffmann, M. et al. (2020). “SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.” Cell, 181(2):271–280.e8. doi:10.1016/j.cell.2020.02.052
Hosier, H. et al. (2020). “SARS-CoV-2 infection of the placenta.” Journal of Clinical Investigation, 130(9):4947–4953. doi:10.1172/JCI139569
Khamzaeva N.T., Matnazarova G.S., Saidkasimova N.S., Abdukakharova M.F. Retrospective epidemiological analysis of COVID-19 infection in Tashkent city during 2020–2023. In: Modern Trends and Development Factors in the Application of Digital Technologies in Education, Vol. 31, Part 1. May 2024, pp. 189–193.
Li, M. et al. (2020). “Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues.” Infectious Diseases of Poverty, 9(1):45. doi:10.1186/s40249-020-00662-x
Lindholm K., O’Keefe M. Archives of Pathology & Laboratory Medicine. 2019;143(5):639–642.
Parakhina M.V., Esaulov A.D., Rusika A.A. Pathomorphology, clinical manifestations, treatment methods, and prevention in the novel coronavirus infection. Clinical and Experimental Morphology. 2025;14(1):13–19. DOI: 10.31088/CEM2025.14.1.13-19.
Parakhina M.V., Esaulov A.D., Rusika A.A. Pathomorphology, clinical manifestations, treatment methods, and prevention in the novel coronavirus infection. Clinical and Experimental Morphology. 2025;14(1):13–19. DOI: 10.31088/CEM2025.14.1.13-19. (Duplicate)
Schwartz, D.A. (2020). “An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes.” Archives of Pathology & Laboratory Medicine, 144(7):799–805. doi:10.5858/arpa.2020-0901-SA
Svarovskaya A.V., Astanin P.A., Vende A.D. Evaluation of the prognostic significance of laboratory parameters as risk factors for fatal outcomes in patients with the novel coronavirus infection (COVID-19). Complex Problems of Cardiovascular Diseases. 2025;14(2):168–177. DOI: 10.17802/2306-1278-2025-14-2-168-177.
Zhu, N. et al. (2020). “A Novel Coronavirus from Patients with Pneumonia in China, 2019.” New England Journal of Medicine, 382(8):727–733. doi:10.1056/NEJMoa2001017
